|
| 37876360 | IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model. | Pharmacoepidemiol Drug Saf | 2024 |
| 38042335 | Applying Trial-Derived Treatment Effects to Real-World Populations: Generalizing Cost-Effectiveness Estimates When Modeling Complex Hazards. | Value Health | 2024 |
| 37833846 | Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation. | Int J Epidemiol | 2024 |
| 37876360 | IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model. | Pharmacoepidemiol Drug Saf | 2024 |
| 37833846 | Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation. | Int J Epidemiol | 2024 |
| 38042335 | Applying Trial-Derived Treatment Effects to Real-World Populations: Generalizing Cost-Effectiveness Estimates When Modeling Complex Hazards. | Value Health | 2024 |
| 35012410 | Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe. | J Asthma | 2023 |
| 36352763 | Impact of the COVID-19 pandemic on eating disorders diagnoses among adolescents and young adults in Catalonia: A population-based cohort study. | Int J Eat Disord | 2023 |
| 36264262 | Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the Global South. | J Am Med Inform Assoc | 2023 |
| 37724311 | Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research. | Clin Epidemiol | 2023 |
| 37033631 | Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study. | Front Pharmacol | 2023 |
| 36750857 | Association between outpatient follow-up and incidence of revision after knee and hip replacements: a population-based cohort study. | BMC Musculoskelet Disord | 2023 |
| 36730480 | Dupuytren Disease: Prevalence, Incidence, and Lifetime Risk of Surgical Intervention. A Population-Based Cohort Analysis. | Plast Reconstr Surg | 2023 |
| 36662166 | Expected Benefits and Budget Impact From a Microsimulation Model Support the Prioritization and Implementation of Fracture Liaison Services. | J Bone Miner Res | 2023 |
| 35012410 | Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe. | J Asthma | 2023 |
| 37724311 | Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research. | Clin Epidemiol | 2023 |
| 37033631 | Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study. | Front Pharmacol | 2023 |
| 36750857 | Association between outpatient follow-up and incidence of revision after knee and hip replacements: a population-based cohort study. | BMC Musculoskelet Disord | 2023 |
| 36730480 | Dupuytren Disease: Prevalence, Incidence, and Lifetime Risk of Surgical Intervention. A Population-Based Cohort Analysis. | Plast Reconstr Surg | 2023 |
| 36662166 | Expected Benefits and Budget Impact From a Microsimulation Model Support the Prioritization and Implementation of Fracture Liaison Services. | J Bone Miner Res | 2023 |
| 36352763 | Impact of the COVID-19 pandemic on eating disorders diagnoses among adolescents and young adults in Catalonia: A population-based cohort study. | Int J Eat Disord | 2023 |
| 36264262 | Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the Global South. | J Am Med Inform Assoc | 2023 |
| 34655476 | Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4â¿¿618â¿¿377 adults in Catalonia, Spain. | Int J Cancer | 2022 |
| 35396302 | Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study. | BMJ Open | 2022 |
| 35576963 | Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. | Lancet Infect Dis | 2022 |
| 36288813 | Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. | BMJ | 2022 |
| 36220130 | Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain. | Emerg Infect Dis | 2022 |
| 35415748 | Data Resource Profile: The Information System for Research in Primary Care (SIDIAP). | Int J Epidemiol | 2022 |
| 35728447 | Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis. | Semin Arthritis Rheum | 2022 |
| 36418321 | Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain. | Nat Commun | 2022 |
| 36418291 | Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. | Nat Commun | 2022 |
| 35296468 | Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. | BMJ | 2022 |
| 35191114 | Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. | Pharmacoepidemiol Drug Saf | 2022 |
| 34655476 | Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4â¿¿618â¿¿377 adults in Catalonia, Spain. | Int J Cancer | 2022 |
| 35094685 | Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. | BMC Med Res Methodol | 2022 |
| 35345821 | Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS. | Clin Epidemiol | 2022 |
| 35345821 | Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS. | Clin Epidemiol | 2022 |
| 35576963 | Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. | Lancet Infect Dis | 2022 |
| 35728447 | Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis. | Semin Arthritis Rheum | 2022 |
| 35396302 | Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study. | BMJ Open | 2022 |
| 35415748 | Data Resource Profile: The Information System for Research in Primary Care (SIDIAP). | Int J Epidemiol | 2022 |
| 36418321 | Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain. | Nat Commun | 2022 |
| 36418291 | Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. | Nat Commun | 2022 |
| 36288813 | Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. | BMJ | 2022 |
| 36220130 | Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain. | Emerg Infect Dis | 2022 |
| 35191114 | Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. | Pharmacoepidemiol Drug Saf | 2022 |
| 35094685 | Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. | BMC Med Res Methodol | 2022 |
| 35296468 | Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. | BMJ | 2022 |
| 33269356 | Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States. | medRxiv | 2021 |
| 34297116 | Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: A Cohort Study of 2 524 926 Catalans. | J Clin Endocrinol Metab | 2021 |